An
alarming increase in antibiotic-resistant bacterial strains
is driving clinical demand for new antibacterial agents. One of the
oldest antimicrobial agents is elementary silver (Ag), which has been
used for thousands of years. Even today, elementary Ag is used for
medical purposes such as treating burns, wounds, and microbial infections.
In consideration of the effectiveness of elementary Ag, the present
researchers generated effective antibacterial/antibiofilm agents by
combining elementary Ag with biocompatible ultrashort peptide compounds.
The innovative antibacterial agents comprised a hybrid peptide bound
to Ag nanoparticles (IVFK/Ag NPs). These were generated by photoionizing
a biocompatible ultrashort peptide, thus reducing Ag ions to form
Ag NPs with a diameter of 6 nm. The IVFK/Ag NPs demonstrated promising
antibacterial/antibiofilm activity against reference Gram-positive
and Gram-negative bacteria compared with commercial Ag NPs. Through
morphological changes in Escherichia coli and Staphylococcus aureus, we proposed
that the mechanism of action for IVFK/Ag NPs derives from their ability
to disrupt bacterial membranes. In terms of safety, the IVFK/Ag NPs
demonstrated biocompatibility in the presence of human dermal fibroblast
cells, and concentrations within the minimal inhibitory concentration
had no significant effect on cell viability. These results demonstrated
that hybrid peptide/Ag NPs hold promise as a biocompatible material
with strong antibacterial/antibiofilm properties, allowing them to
be applied across a wide range of applications in tissue engineering
and regenerative medicine.